The board meeting for Maze Therapeutics Inc is scheduled for today, for the purpose of Maze Therapeutics Inc Annual General Meeting for 2025See details
Maze Therapeutics Inc has a share price target of US$ 60, revenue growth forecast of -99.3%, and profit growth estimate of -3937.8% for FY26, based on top 12 analyst calls.